Unknown NA INTERVENTIONAL 2-arm NCT02724761

Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion

Prophylactic Racemic Epinephrine for the Prevention of Dysphagia in Patients Undergoing Anterior Cervical Discectomy and Fusion: A Randomized Control Trial

Sponsor: Andrew Chung

Conditions Dysphagia Dysphonia Postoperative Pain

Interventions Placebo (for racemic epinephrine) Racemic Epinephrine

Updated 6 times since 2017 Last updated: Mar 30, 2016 Started: Sep 30, 2016 Primary completion: Jun 30, 2018 Completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02724761, this NA trial focuses on Dysphagia and Dysphonia and remains ongoing. Sponsored by Andrew Chung, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Oct 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Oct 2018 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Andrew Chung
Banner Health
More Foundation

Data source: Banner Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States